baber/WOPTO huggingface dataset:
Patent CS-260061-B1 (CS)
Inventor: SYNEK PAVEL
IPC: H03M1/12
Filed: 1986-12-27
Abstract: Zapojení obvodu vyhodnocení je určeno
pro konstrukci zařízení pro vyhodnocení
magnetického záznamu na povrchu dopravních
prostředků. Skládá se z budicího zdroje,
čtecího obvodu, vyhodnocovacího obvodu,
dvojice komparátorů s nastavitelnými . referenčními obvody, dvou oddělovacích
a signalizačních obvodů a výstupního obvodu
připojitelného na sběrnici mikroprocesorového
systému. Zapojení pracuje tak, že při
přiblížení boční stěny dopravního prostředku
označeného magnetickým záznamem ke čtecímu
obvodu nastane změna signálů vysílaných
do vyhodnocovacího obvodu, který podle
druhu vyhodnoceného záznamu pošle signál
do jednoho ze dvou komparátorů. Oroveň
tohoto signálu se porovná s výstupem
z nastavitelného referenčního obvodu.
Signál získaný z výstupů komparátorů je
přiveden přes oddělovací a signalizační
obvody do výstupního obvodu. Zapojení
vykazuje vysokou citlivost a stabilitu
vyhodnocovaných úrovní magnetických
záznamů.
Patent DK-174931-B1 (DK)
Inventor: ANDOH HIDENOBU
IPC: A61K47/44
Filed: 1987-07-17
Granted: 2004-03-01
Abstract: A sustained-release drug preparation comprises a water-soluble drug, a lipidic substance and an oil as its essential components. The drug level in the blood is sustained at a preferable concentration for a long period of time.
Patent FI-102035-B1 (FI)
Inventor: BAR-SHALOM DANIEL
IPC: A61K8/60
Filed: 1991-10-16
Granted: 1998-10-15
Abstract: A method of treating and/or preventing alopecia (baldness, deficient hair growth) comprises administering to a patient in need thereof a therapeutically or prophylactically effective amount of a sulfated mono-, di- or oligosaccharide or a derivative, salt or complex thereof. The saccharide is preferably polysulfated, such as a polysulfated disaccharide, in particular sucrose, or a derivative, complex or salt thereof. Especially interesting polysulfated disaccharides are sucrose pentasulfate, sucrose hexasulfate, sucrose heptasulfate, and sucrose octasulfate, e.g. in the form of a potassium or sodium salt, or in the form of sucralfate.
Patent FI-103613-B1 (FI)
Inventor: SJOEBLOM JARKKO
IPC: B65H51/14
Filed: 1998-03-26
Granted: 1999-07-30
Abstract: An arrangement in connection with a belt drive device having two counter-rotating continuous belts operated by drive rollers traveling around stretching rollers, whereby the belts are urged towards one another by press rolls to draw a cable between the belts. Adjustment of the stretching rollers is provided by an adjustment mechanism that effects the axle with which the stretching rollers are associated.
Patent IE-39575-B1 (IE)
Title: Container closures
IPC: B65D41/44
Filed: 1974-05-17
Abstract: 1464577 Metal closure AMERICAN FLANGE & MFG CO Inc 13 May 1974 [23 May 1973] 21045/74 Heading B8T A metallic closure has a circular cap portion 2 stiffened by means of an annular embossment 11 which itself surrounds a circular embossment 13 the cap being integral with a cylindrical skirt 4, two score lines 6 passing across the surface of the cap and skirt and defining between them a tear strip 7 which extends in a direction perpendicular to the grain structure of the cap material, the score lines being ruptured at the time of opening by means of a pull tab 8. A gasket 10 is secured to the junction between cap and skirt.
[GB1464577A]
Patent IE-49721-B1 (IE)
Title: Improvements in or relating to a formwork system
IPC: E04G11/48
Filed: 1980-07-11
Abstract: In a formwork system frames (1) are mounted between horizontal supports (7). The support means (4) on the frames (1) are offset relative to the horizontal axis so that the inversion of the frames enables the level of the upper surface thereof to be adjusted. Thus the same components can be used to make a formwork for fine finish concrete or standard finish. In an alternative embodiment the support means on the horizontal support (7) is offset so that the adjustment can be effected by reversing the support (7).
Patent IE-41487-B1 (IE)
Title: Novel derivatives of 11-hydroxytestosterone process for preparing them and uses for them
IPC: C07J41/00
Filed: 1975-07-04
Abstract: 1510841 11-Substituted testasterone ROYSSEL-UCLAF 4 July 1975 [4 July 1974] 28185/75 Heading C2U [Also in Division C3] The invention comprises compounds of formula wherein Y is -O-CO-(CH 2 ) n -CO 2 H or (where n is 1-18), with the exclusion of the 11α-hemisuccinate; and their preparation by reduction of the corresponding 17-ones, in which, in the case of the 11-hemiterephthalates, the carboxy group is protected by alkylation and the 3-oxo-#4 grouping is protected by enol alkylation. Conjugates of compounds I with bovine serum albumin are prepared by the mixed anhydride method. Intermediates prepared are: 11#-(3-carboxypropionyloxy)androst - 4 - ene - 3,17 - dione; 11α- and 11# - [p - (methoxycarbonyl)benzoyloxy]androst - 4 - ene - 3,17 - dione; 11α- and 11# - [p - (methoxycarbonyl)benzoyloxy] - 3- ethoxyandrosta - 3,5 - diene - 17 - one; 11α- [p - (methoxycarbonyl)benzoyloxy] - 3 - ethoxyandrosta - 3,5 - diene - 17# - ol; 11α - [p- (methoxycarbonyl)benzoyloxy] - 17# - hydroxy. androst-4-en-3-one; and 11#-(p-carboxybenzoyloxy)-3-ethoxyandrosta-3,5-dien-17#-ol.
Patent IE-48833-B1 (IE)
Title: Preparation of glyceride esters
IPC: C07C69/30
Filed: 1979-09-18
Abstract: The invention concerns the preparation of glycerides in which glycidol is reacted with a fatty acid, first in the form of the anhydride to produce the corresponding epoxy glyceride or glycidol ester, at the same time liberating free fatty acid from the anhydride and thereafter continuing reaction, this time between the liberated free fatty acid or another acid, in the presence of an acylation catalyst under the influence of which the oxirane ring is ruptured and diglycerides produced. These may be used in the preparation of svnthetic fats.
Patent IE-51466-B1 (IE)
Title: Pyrollo(3,4-d)(2)benzazepines,intermediates and process for their preparation,and medicaments containing them
IPC: C07D487/04
Filed: 1981-08-14
Abstract: Pyrrolo (3,4-d) benzazepine derivs. (I) and their acid addn. salts where A is a group of formula (Ia) are new: A is a group of formula (Ia), (Ib), (Ic), (Id) or (Ie); R1 is H, lower alkyl 3-7C alkenyl, 3-7C alkynyl, CH2OH or -CO-R11; R11 is H, OH, alkoxy, NH2 or mono- or di (lower) alkyl imino; R3 is H, lower alkyl, 3-7C alkenyl, 3-7C alkynyl, CH2OH or -CO-R111; R111 is H, OH, trihalomethyl, alkoxy, NH2 or mono- or di(lower alkyl)amino; R2 is H, lower alkyl, 3-7C alkenyl, 3-7C alkynyl, -COO (lower alkyl), a 2-7C carboxylic acid residue or ester or amide thereof, hydroxy-(2-7C alkyl), or amino- or mono- or di(lower alkyl)amino (2-7C alkyl); R5 is H, F, Cl or Br; R6 is F, Cl or Br; R95 is lower alkyl; and Z is the anion of an acid. Provisos are that (a) when one of R1 and R3 is hydroxymethyl, -CO-R11 or -CO-R111 then the other of R1 and R3 is H, lower alkyl, 3-7C alkenyl or 3-7C alkynyl and R2 is H, (b) when R4 is acyloxy, then R1 and R3 are H, lower alkyl, 3-7C alkenyl or 3-7C alkynyl and R2 is -CO-(lower alkoxy), (c) when R4 is OH then R1 and R3 are H, lower alkyl, 3-7C alkynyl or 3-7C alkenyl and R2 is H, (d) when R4 is unbranched lower alkoxy, then R1 and R3 are H, lower alkyl 3-7C alkenyl or 3-7C alkynyl, (e) when A is a group (Ib), (Ic), (Id) or (Ie), then R4 is H and (f) when A is a group (Ib) or (Ie), then R2 is other than amino- or mono- or di- (lower alkyl) amino- (2-7C alkyl)). Also new and claimed are intermediates to (I) and their precursors (I) have sedative and anxiolytic activity.
Patent IE-47378-B1 (IE)
Title: Analgesic compounds
IPC: C07K5/08
Filed: 1978-09-26
Abstract: Compounds of the general formula and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D, when applicable, define the chirality; 
R1 and R2 independently are hydrogen or C1-C3 primary alkyl;
R3 is C1-C3 primary or secondary alkyl or-CH2CH2-S-CH3;
R4 is hydrogen or C1-C3 primary alkyl;
R5 is hydrogen or C1-C3 primary alkyl;
Y is hydrogen or acetyl; and
Zis -CH2OH, or -CN; subject to the limitation that
one of R4 and R, is C1-C3 primary alkyl and the other is hydrogen; are useful analgesic agents.
Patent IE-42053-B1 (IE)
Title: New organophosphorus thiazole derivatives, processes for preparing them and pesticidal compositions incorporating them
IPC: A01N57/16
Filed: 1975-09-22
Abstract: 1502890 Organophosphorus thiazole derivatives ROUSSEL-UCLAF 22 Sept 1975 [20 Sept 1974] 38757/75 Headings C2P and C2C The invention comprises compounds of formula (wherein X and Z are each O or S; R is C 1-6 alkyl, C 2-6 alkenyl, C 3-8 cycloalkyl, benzyl, or benzyl mono- or disubstituted on the benzene ring by halogen, Me and/or OMe; R1 is C 1-3 alkyl or C 1-3 alkoxy; and R2 is C 1-3 alkyl); and their preparation from compounds III infra by reaction with ClP(X)(R1)(OR2). Intermediates of formula and salts thereof are prepared from compounds II infra by reaction with a haloacetonitrile in the presence of a base. Intermediates of formula are prepared from ethoxycarbonyl isothiocyanate by reaction with RZH. Pesticidal compositions comprise a compound I and a carrier.
Patent IE-55973-B1 (IE)
Title: The use of undecylenic acid for the manufacture of a composition for the treatment of herpes labialis
IPC: A61P31/12
Filed: 1983-09-26
Abstract: Warm-blooded animals are treated for Herpes simplex virus-I by administering to the animal a dosage, effective to alleviate the symptoms of the virus, of undecylenic acid and at least one pharmaceutically acceptable carrier, wherein the compound is in the range of from about 1 to about 95% by weight of the composition.
[US4520132A]
Patent IE-43778-B1 (IE)
Title: Solid solutions of ergot alkaloids in polymers
IPC: A61K31/48
Filed: 1976-10-15
Abstract: The invention relates to a process for the preparation of a solid material composed of ergot peptide alkaloids, their hydrogenated forms or their salts and polyvinylpyrrolidone. The solid material obtained according to the invention can be used for the preparation of pharmaceutical compositions.
Patent IE-45840-B1 (IE)
Title: Improvements in taps and stop-valves and valve components therefor
IPC: F16K41/10
Filed: 1977-11-11
Abstract: The assembly comprises a cup- shaped valve 9 which has a flat circular disc 10 which seats on the seat 3 of the tap body 1, and a flexible cylindrical skirt which connects the periphery of the disc with an annular flange 12 which is clamped between the head 6 and body 1 of the tap to isolate the head works of the tap from the water flow. An axial valve stem 14 connects the interior face of the disc with a hand control 8. A saucer-shaped bush is disposed in the mouth of the cup valve 9 and has a central polygonal guide aperture through which the valve stem 14 projects, flats 22 on the valve stem mating with the polygonal aperture to prevent relative rotation of the guide bush and stem. The annular flange 12 of the cup-valve is compressed against a rim portion of the guide bush to prevent rotation of the bush. In this way the setting up of torques in the flexible skirt of the cup-valve is prevented on opening and closing of the tap and a positive stop in the rotation of the control is obtained. To provide a tamper-proof hand-control 8 the non-rising spindle 7 connected thereto is prevented from being lifted out of engagement with the interior of the tap head 6 by means of a circlip on the lower end of the spindle.
Patent IE-57311-B1 (IE)
Title: Surgical hemostat comprising oxidized cellulose
IPC: A61F13/00
Filed: 1985-10-04
Abstract: A surgical hemostat comprising oxidized cellulose having a warp knit tricot construction which provides a fabric density of at least 0.03 g/cm2. air porosity of less than 150 cm3/sec/cm2, and liquid absorption of at least 3 times the dry weight of the fabric.
Patent IE-50580-B1 (IE)
Title: 2-acylaminomethyl-1,4-benzodiazepines and salts thereof,methods of preparing them and preparations containing these compounds
IPC: C07D213/81
Filed: 1980-12-04
Abstract: Novel 2-acylaminomethyl-1H-2,3-dihydro-1,4-benzodiazepine derivatives are disclosed which possess the Formula I <IMAGE> (I) wherein R1 represents hydrogen, lower akyl, lower alkenyl or cyclopropylmethyl; R2 represents hydrogen, lower alkyl or lower alkenyl; R3 represents a group of the formula a, b, c or d; <IMAGE> +TR <IMAGE> wherein R is hydrogen or C1-C3- alkyl; R4 is hydrogen, lower alkyl, lower alkoxy, nitro or halogen, and R4' is hydrogen or C1-C4- alkyl and the aromatic groups A and B may be unsubstituted or substituted by 1 to 3 substituents such as halogen, lower alkylthio, lower alkoxy, lower alkyl, hydroxy, nitro, trifluoromethyl or methylenedioxy or ethylenedioxy and optical isomers and acid addition salts of the compounds. In addition to psycho pharmacological, diuretic and antiarrhythmic properties, the novel compounds of Formula I possess primarily outstanding analgesic activities and are low in toxicity. The compounds are prepared by acylating 2-aminomethyl-1,4-benzodiazepine derivatives with corresponding carbonic acid derivatives. Furthermore, 2-azidomethyl-1,4-benzodiazepine derivatives are disclosed which provide valuable intermediates for the preparation of the compounds of Formula I yet also possess themselves pharmacological activities.
[US4325957A]
Patent IE-55761-B1 (IE)
Title: Wire mesh well screen with welded wire support
IPC: B01D29/11
Filed: 1984-10-17
Abstract: Improved well screen has its open area defined by a helically wrapped strip of wire mesh which is supported by a rigid cage-like structure of welded steel longitudinal support rods and helical wrap wires. The design is cost competitive with the simple, and rather fragile, screens made by wrapping a mesh about a perforated pipe while offering the mechanical strength characteristics of wire-wrapped welded screens and a substantially larger open area for flow. The wire mesh strip is helically wound with a gap and at least one wrap wire is helically wound in the gap so that a small portion of its width can be firmly adhered to the rods while at least another portion of its width overlies an adjacent side edge of the mesh strip.
[US4494603A]
Patent IE-53361-B1 (IE)
Title: A fastening means for padlocks and the like
IPC: E05B67/38
Filed: 1981-12-04
Abstract: A fastening means for shutters, doors or windows, particularly as a "ground lock" for roller shutters, comprises: an eye-bolt (3) forming a staple removably screwed into an anchorage element (2) secured in the group and having an internally threaded portion (11) spaced from the open end of the anchorage element (2); and an abutment member (40) secured to the leading edge of the shutter (1), door or window, and having a slot (48) into which the eyebolt (3) can pass. The abutment member (40) comprises a hasp portion (43) and two wall portions (44, 45) forming a housing for a padlock (41). A guard plate (52) is provided at one end of the abutment member to bridge the wall portions (44,45) and prevent the bolt being forcibly driven through the padlock. In a second embodiment, the abutment member has no wall portions but has an upstanding lug adjacent the slot, the lug having an aperture adapted to register with the aperture of the eyebolt so that both apertures can receive the bolt or shackle of a lock.
Patent IE-53986-B1 (IE)
Title: Process for the preparation of bicycloheptane derivatives, and novel bicycloheptane derivatives
IPC: C07C35/18
Filed: 1982-12-14
Abstract: A process for the preparation of a 2-exo-hydroxy-7-oxa-bicyclo[2.2.1]heptane, wherein the corresponding cis 3,4-expoxycyclohexanol is cyclised by treatment with an acid. Specific 2-exo-hydroxy-7-oxabicyclo[2.2.1]heptanes and intermediates thereof.
Patent IE-65526-B1 (IE)
Title: Mechanical fatigue test bench for engine cylinder heads
Inventor: COFFLARD DANIEL
IPC: G01M15/04
Filed: 1990-08-28
Abstract: This invention relates to a fatigue test bench for engine cylinder heads, particularly for motor vehicles. This bench comprises as main elements: a device for fixing the test cylinder head on an intermediate connecting member, connecting it to the means of establishing hydraulic pressure in the combustion chambers and in the circulating of the heat bearing fluids; a pressure generating device which simulates as faithfully as possible and in a reproducible manner the pressure cycle as a function of time in the combustion chambers; and a system of circulating heat bearing fluids through the water chambers of the cylinder head with two differnt circuits, one at ambient temperature and the other at a higher temperature used alternately by means of a regulable timing device which controls the operation of one or other of the circuits. The apparatus according to the invention makes it possible in a limited time, generally less than half the time required for tests on an engine bench: for a given type of cylinder head, to define the most suitable alloy or alloys; to develop new alloy compositions which are more suitable for the increasingly more severe demands encountered in the field of motor vehicle cylinder heads; to rapidly test new forms of cylinder heads; and to draw up comparative data of resistance to mechanical fatigue.
Patent IE-67640-B1 (IE)
Title: Process for the chemical resolution of 5-alkoxy-substituted (+)-1,3-dimethyloxindolylethylamines
Inventor: LEE THOMAS B K
IPC: C07B57/00
Filed: 1990-09-18
Abstract: A process for chemically resolving a mixture of enantiomers of primary amines, such as enantiomers of 1,3-dimethyl-5-methoxyoxindolylethylamine, provides one of the enantiomers in the form of a tartaric acid salt. In carrying out the process, an enantiomeric mixture is contacted with a chiral acid in an amount sufficient to preferentially precipitate a salt of the chiral acid and one of the enantiomers. The resulting precipitate can then be recovered. The chiral acid is selected from the group consisting of dibenzoyl-D-tartaric acid, dibenzoyl-L-tartaric acid, ditoluoyl-D-tartaric acid, and ditoluoyl-L-tartaric acid. The precipitates can be used in the synthesis of stereospecific forms of physostigmine.
Patent IE-63339-B1 (IE)
Title: Oral compositions
Inventor: BURGESS STEVEN CARL
IPC: A61K8/34
Filed: 1989-11-08
Abstract: Toothpaste compositions are disclosed which contain a silica abrasive which is very compatible with cationic therapeutic agents and agents of those types. The compositions are also formulated with other formula components which maximize the availability of the agents.
Patent IE-66486-B1 (IE)
Title: Silicon infiltrated porous polycrystalline diamond compacts and their fabrication
Inventor: CHO HYUN SAM
IPC: C04B41/50
Filed: 1989-11-29
Abstract: Disclosed is a method for producing a polycrystalline diamond compact which comprises providing a thermally-stable compact comprising between about 70% and 95% by volume diamond, characterized by a network of interconnected, empty pores dispersed throughout, and containing between about 0.05% and 3% by volume of a catalyst/sintering aid material; and subjecting said thermally-stable compact and a silicon material to a partial vacuum at an elevated temperature for a time adequate for said silicon material to infiltrate into said compact pores. The silicon material has a melting point not above about 1410 DEG C and preferably is a silicon alloy having a melting point range of between about 800 DEG  and 1400 DEG C.
Patent LU-500740-B1 (LU)
Title: REAL-TIME FLUORESCENT PCR DETECTION PRIMERS AND PROBES, KIT AND METHOD FOR NOVEL CORONAVIRUS 2019-nCoV
Inventor: HUA LINLIN
IPC: G01N33/00
Filed: 2021-10-18
Granted: 2022-05-03
Abstract: The present invention discloses real-time fluorescent quantitative PCR detection primers and probes, kit and method for novel coronavirus 2019-nCoV (also called 2019-nCoV). The present invention selects two sites in nucleic acid after 2019-nCoV replication for detection, wherein both of the two sites are specific to 2019-nCoV. The detection kit has high specificity and has no cross-reaction with the total nucleic acid of other common pathogens that have the same site of infection or similar symptom of infection as 2019-nCoV and human white blood cells. The present invention uses a single tube with three fluorescence channels to simultaneously detect the presence of novel coronavirus 2019-nCoV and reference gene Rnase P, which can detect the presence of novel coronavirus 2019-nCoV RNA in alveolar lavage fluid, nasal swabs, throat swabs and other samples. The present invention has a short detection time, which can be as low as 1.5 h, is suitable for rapid detection and diagnosis in clinical settings, with high specificity, high repeatability, high sensitivity and high accuracy for detection of 2019- nCoV viruses.
Patent LU-502262-B1 (LU)
Title: Software defect detection method with effective data processing
Inventor: MA YING
IPC: G06F11/36
Filed: 2022-06-13
Granted: 2022-12-13
Abstract: A software defect detection method with effective data processing comprises detecting a received software module, acquiring an original software metric data set and preprocessing data of the original software metric data set, dividing the data into training samples and testing samples, substituting training sample data into a dictionary learning model and discriminating, structuring the dictionary, evaluating performance by an asymmetric classifier, detecting the transferred testing samples, performing a defect detection on a software detection module by the dictionary learning model, and transmitting evaluation results to testers to complete test. The method enhances a dictionary representation ability, has a good discrimination performance, effectively solves errors caused by a data imbalance problem, and accurately locates a software defect position.
Patent NO-305784-B1 (NO)
Inventor: HUNZIKER ERNST B
IPC: A61K38/18
Filed: 1994-03-04
Abstract: Kits and compositions are provided for the treatment and repair of defects in the cartilage or bone of humans and other animals as in full-thickness defects in joints. A matrix having pores large enough to allow cells to populate the matrix and to form blood vessels is used to fill the defect in bone. The matrix filling the bone defect contains an angiogenic factor and also contains an osteogenic factor in an appropriate delivery system. A matrix having pores sufficiently large to allow cartilage repair cells to populate the matrix is used to fill a defect in cartilage to induce cartilage formation. The matrix filling the defect in cartilage contains a proliferation agent and also contains a transforming factor in an appropriate delivery system. The matrix may also contain a chemotactic agent to attract cartilage repair cells. In a full-thickness defect, a membrane is used to separate the defect sites in bone and cartilage, which is sealed to the cartilage-bone-junction and which prevents blood vessels and associated cells from penetrating from one site to the other.
Patent NO-314435-B1 (NO)
Title: Lav-viskositets oftalmisk blanding
Inventor: REUNAMAEKI TIMO
IPC: A61K9/08
Filed: 1996-09-27
Abstract: Foreliggende oppfinnelse vedrører en ophtalmisk blanding i form av en topisk vandig løsning som består vesentlig av et ophtalmologisk aktivt middel som inneholder basiske grupper, en. ionfølsom, hydrofil polymer som inneholder syregrupper, i en mengde på 0,004 til 1,5 vekr%,. minst ett salt utvalgt fra gruppen uorganiske salter og buffere, i en total mengde på 0,01 til 2,0 vekt% og valgfritt et fuktemiddel og et konserveringsmiddel, hvor forholdet mellom saltet og polymeren i er slik at løsningen oppviser en viskositet på mindre enn 1000 mPas, og pH-verdien for løsningen er fra 4,0 til 8,0. Blandingen inneholder en tilstrekkelig mengde .polymer for å gi en kontrollert absorpsjon av legemidlet inn i øyet, og blandingens viskositet er blitt senket for å gi bedre hånderingskarakteristikker.